Concepedia

Rachel E. Behrman

RE

Statistics

Publications

6

Citations

1K

H-Index

6

Active since

1989

Affiliations

United States Food and Drug Administration(Current)

University of New Mexico

University of Utah

National Center for Infectious Diseases

Centers for Disease Control and Prevention

Rachel E. Behrman is an author at United States Food and Drug Administration specializing in medicine, virology, and covid-19.

Top concepts

MedicineCovid-19VirologyHepatitisBig DataPathologyStatisticsDrug DesignEngineeringData Science

Publications per year

1989–2011

6

Publications

6

Developing the Sentinel System — A National Resource for Evidence Development

Rachel E. Behrman, Joshua S. Benner, Jeffrey S. Brown et al. · New England Journal of Medicine · 2011 · 327 citations

A National Resource, Engineering, Data Science +15

Development of Novel Combination Therapies

Janet Woodcock, Joseph P. Griffin, Rachel E. Behrman · New England Journal of Medicine · 2011 · 247 citations

Successful Development, Translational Medicine, Medical Treatment +15

Intravenous Ribavirin for Hantavirus Pulmonary Syndrome: Safety and Tolerance during 1 Year of Open-Label Experience

Louisa E. Chapman, Grégory Mertz, C. J. Peters et al. · Antiviral Therapy · 1999 · 168 citations

Diagnostic Virology, Hantavirus Pulmonary Syndrome, Viral Diagnostics +15

Zidovudine, Didanosine, or Both as the Initial Treatment for Symptomatic HIV-Infected Children

Janet A. Englund, Carol J. Baker, Claire Raskino et al. · New England Journal of Medicine · 1997 · 156 citations

Discriminators between Hantavirus-Infected and -Uninfected Persons Enrolled in a Trial of Intravenous Ribavirin for Presumptive Hantavirus Pulmonary Syndrome

Louisa E. Chapman, B. A. Ellis, Frederick Koster et al. · Clinical Infectious Diseases · 2002 · 80 citations

Diagnostic Virology, Clinical Symptoms, Hantavirus Pulmonary Syndrome +15

1–5 of 6